Moderna (MRNA) stock crashed Thursday after a third-party leaked the purported cancer vaccine data ahead of a hotly-anticipated presentation Saturday at the European Society of Clinical Oncology Congress. Data showed that their mRNA cancer vaccine merely reduced risk of recurrence or death by 42%, a far fetch from the “cancer cure” narrative that retail has been pushing as they have bid the stock up over the last 2 months.
CryptoAlerta — análise de criptomoedas e mercado em tempo real